Data Gaps that Create Pharma R&D Waste
13 February 2026 Category: Clinical TrialPharma R&D waste is often mistaken for scientific failure. In reality, a large portion of it is strategic and preventable.
Pharma R&D waste is often mistaken for scientific failure. In reality, a large portion of it is strategic and preventable.
The generic injectable market is not glamorous. It is not trendy either. But it prints money.
The biosimilar market is getting bigger, faster, and honestly a little chaotic. Patent cliffs are coming one after another, biologics are losing exclusivity across the world, and every pharma company wants a piece of the action.
Bottom line is, 2026 will is going to be one of the most important years for healthcare sector. So let’s dive in, and get a better look at what next year have up it’s sleeves.
The global herbal medicine market is booming, and at its heart lies Traditional Chinese Medicine (TCM).